Product image of Nelya (Ethinylestradiol, Gestodene | Lactose) supplied by GNH India

Nelya

Active Ingredient:
Ethinylestradiol, Gestodene | Lactose
Origin:
EU

Nelya (Ethinylestradiol, Gestodene | Lactose)

Ethinylestradiol and Gestodene, the active ingredients in Nelya, are combined oral contraceptives presented as tablets for oral use. They are prescribed to prevent pregnancy by suppressing ovulation and stabilising the endometrium.\nGNH India supplies Nelya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Heaton K.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Nelya is a combined oral contraceptive that acts on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy and manage menstrual disorders.\n- Contraception: Prevents pregnancy by inhibiting ovulation and altering cervical mucus.\n- Menstrual cycle regulation: Provides regular, predictable bleeding patterns for women with irregular cycles.\n- Management of dysmenorrhea: Reduces menstrual pain by stabilising endometrial growth.

How It Works

  • Ethinylestradiol and Gestodene bind to estrogen and progestogen receptors, respectively, suppressing the release of gonadotropins (FSH and LH) from the pituitary gland. This inhibition prevents follicular development and ovulation. The progestogen component also thickens cervical mucus and induces endometrial changes that reduce the likelihood of implantation.

Side Effects

  • Nelya may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Nausea: mild to moderate stomach upset.\n- Breast tenderness: temporary swelling or discomfort.\n- Headache: occasional mild to moderate pain.\n- Spotting or breakthrough bleeding: irregular light bleeding between periods.\n- Mood changes: mild fluctuations in mood or irritability.\n- Weight gain: modest fluid retention or appetite increase.\n\nSerious or Rare Side Effects:\n- Venous thromboembolism: blood clots in deep veins or lungs.\n- Arterial thrombosis: clot formation in arteries leading to stroke or heart attack.\n- Severe hypertension: sudden, high blood pressure.\n- Liver tumor: benign hepatic adenoma.\n- Allergic reaction: rash, itching, swelling, or anaphylaxis.\n- Severe depression or suicidal thoughts.

Precautions & Warnings

  • Before prescribing Nelya, clinicians should evaluate individual risk factors and counsel patients on safe use.\n- Cardiovascular assessment: review history of thrombosis, hypertension, or smoking.\n- Liver function: check for hepatic disease that may alter hormone metabolism.\n- Drug interaction review: identify concurrent use of enzyme‑inducing agents.\n- Pregnancy testing: ensure patient is not already pregnant before initiation.\n- Breastfeeding guidance: discuss potential effects on lactation.\n- Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

  • Nelya can interact with several medicines that affect hormone metabolism or clotting risk.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.\n- Anticoagulants (e.g., warfarin): combined use may increase thrombotic risk.\n- Selective serotonin reuptake inhibitors (high dose): may heighten risk of serotonin syndrome when used with certain hormonal agents.\n\nModerate Interactions (Monitor Closely):\n- Antibiotics such as tetracycline or metronidazole: may slightly lower effectiveness.\n- Antifungals (e.g., ketoconazole, itraconazole): can increase hormone levels, raising side‑effect potential.\n- Herbal supplements like St. John’s wort: may diminish contraceptive protection.

Frequently Asked Questions

Nelya is a prescription tablet that combines ethinylestradiol and gestodene to provide reliable contraception. It prevents pregnancy by suppressing ovulation, stabilising the endometrium, and altering cervical mucus, and it can also help regulate menstrual cycles for women with irregular periods.

Ethinylestradiol (an estrogen) and gestodene (a progestogen) bind to their respective hormone receptors, inhibiting the release of gonadotropins from the pituitary gland. This stops follicular development and ovulation, while the progestogen component thickens cervical mucus and creates an endometrial environment that is unfavorable for implantation.

The dosing regimen for Nelya is determined by the prescribing healthcare professional. Typically, combined oral contraceptives are taken once daily for a defined cycle, but the exact schedule, tablet strength and duration should be individualized by the prescriber based on patient needs.

Nelya is intended for use only when a woman is not pregnant. If pregnancy occurs, the product should be discontinued and medical advice sought. Limited data are available for breastfeeding; clinicians usually advise caution and may recommend alternative contraception methods during lactation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nelya contains ethinylestradiol and gestodene, a low‑dose progestogen that offers a favorable bleeding profile and lower androgenic activity compared with some older formulations. Its efficacy and safety are comparable to other second‑generation combined oral contraceptives, but individual tolerability may differ.

Nelya tablets should be stored at ambient temperature, below 25 °C, in the original blister pack to protect them from moisture and light. Keep the medication out of reach of children and do not use if the packaging is damaged.

Nelya is taken orally, usually once a day at the same time each day. The typical regimen involves a 21‑day active tablet phase followed by a 7‑day hormone‑free interval, during which withdrawal bleeding occurs. Patients should follow the specific schedule provided by their prescriber.

The most serious risks include venous thromboembolism, arterial thrombosis (stroke or myocardial infarction), severe hypertension, and rare liver tumors. Patients should be screened for cardiovascular risk factors and advised to seek immediate medical attention if they experience symptoms such as leg pain, chest pain, severe headache, or visual changes.

Nelya is contraindicated in women with a history of thromboembolic disorders, uncontrolled hypertension, active liver disease, known or suspected breast cancer, or those who are pregnant. It should also be avoided in smokers over 35 years of age and in individuals taking strong enzyme‑inducing medications that could reduce its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Gestodene | Lactose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT